-
Most Recent
Kura Oncology
New FDA Approval Could Send Merck Higher
I can’t think of a better way to take advantage of the bullishness than by opening a call option on Merck & Co., Inc. (NYSE:MRK), the healthcare and pharmaceutical company.
It’s Time to Add Some Portfolio Insurance
One stock that is a good candidate for a short-term bearish position is Kura Oncology, Inc. (KURA).